CCCC – c4 therapeutics, inc. (US:NASDAQ)
Stock Stats
News
C4 Therapeutics (CCCC) had its "overweight" rating reaffirmed by Barclays PLC.
C4 Therapeutics (CCCC) had its "buy" rating reaffirmed by TD Cowen.
C4 Therapeutics beats Q4 street views [Seeking Alpha]
C4 Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights [Yahoo! Finance]
C4 Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
Form S-8 C4 Therapeutics, Inc.
Form 10-K C4 Therapeutics, Inc. For: Dec 31
Form 8-K C4 Therapeutics, Inc. For: Feb 26
Form 4 C4 Therapeutics, Inc. For: Feb 13 Filed by: Boyle Scott N
Form 4 C4 Therapeutics, Inc. For: Feb 13 Filed by: Hirsch Andrew
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.